Background Lipoprotein(a) [Lp(a)] is an atherothrombotic plasma lipoprotein
with unknown function. Little is known about the catabolism of this lipopr
otein, in particular the steps related to apolipoprotein(a) [apo(a)] fragme
ntation and excretion by the kidney.
Material and methods High plasma levels (up to 9 mg dL(-1)) of the N-termin
al fragment of apo(a) were expressed in mice by adenovirus mediated gene tr
ansfer. Plasma of such N-apo(a) mice was injected into acceptor mice and th
e fragmentation and urinary secretion of N-apo(a) were followed by immunoch
emical techniques.
Results Mice transduced with N-Ad expressed apo(a)-fragments with 3-11 krin
gle-IV (KIV) repeats. Injection of N-apo(a)-plasma from donor mice into acc
eptor mice resulted in fragmentation of N-apo(a)s with 3-11 KIVs yielding s
maller peptides down to 2 KIVs. Secretion of N-apo(a)-fragments with 2 to m
aximally 6 KIVs into urine occurred as early as 2 min after injection. Immu
nohistochemical studies of kidney suggested filtration as a mechanism of ap
o(a)-fragment excretion.
When N-apo(a) was incubated in vitro with various tissues from perfused mic
e, skeletal muscle and kidney followed by liver and spleen contributed to f
ragmentation. Tissues from unperfused organs, or the addition of normal mou
se plasma, caused marked reduction in N-apo(a) fragmentation. EDTA, and not
aprotinin or leupeptin, prevented apo(a) cleavage.
Conclusion Here we provide evidence that apo(a) is cleaved by metalloprotei
nases located on skeletal muscle, kidney and other organs. Small apo(a)frag
ments up to a size of 6 KIVs are excreted into urine, yet a major portion o
f apo(a) fragments is removed from circulation extrarenally.